Immunovant Inc (IMVT)

Dec 21, 2024

Wells Fargo & Company Issues Pessimistic Forecast for Immunovant (NASDAQ:IMVT) Stock Price - Defense World

Dec 21, 2024

Dec 19, 2024

Wells Fargo & Company Lowers Immunovant (NASDAQ:IMVT) Price Target to $45.00 - MarketBeat

Dec 19, 2024

Dec 19, 2024

Immunovant, Inc. (NASDAQ:IMVT) Receives $47.89 Consensus Target Price from Analysts - MarketBeat

Dec 19, 2024

Dec 18, 2024

Immunovant (NASDAQ:IMVT) Shares Down 5.2%Should You Sell? - MarketBeat

Dec 18, 2024

Dec 17, 2024

Immunovant's SWOT analysis: biotech stock poised for growth in Graves' disease - Investing.com India

Dec 17, 2024

Dec 17, 2024

State Street Corp Buys 303,386 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 17, 2024

Dec 15, 2024

(IMVT) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Dec 15, 2024

Dec 13, 2024

Head to Head Contrast: Jasper Therapeutics (NASDAQ:JSPR) versus Immunovant (NASDAQ:IMVT) - Defense World

Dec 13, 2024

Dec 12, 2024

The Manufacturers Life Insurance Company Has $1.05 Million Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Dec 12, 2024

Dec 08, 2024

Charles Schwab Investment Management Inc. Has $15.75 Million Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 08, 2024

Dec 05, 2024

Redmile Group LLC Decreases Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Immunovant's SWOT analysis: stock undervalued amid promising Graves' disease treatment - Investing.com UK

Dec 05, 2024

Dec 04, 2024

Immunovant director Atul Pande sells shares for $221,185 By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

Immunovant director Atul Pande sells shares for $221,185 - Investing.com

Dec 04, 2024

Dec 04, 2024

(IMVT) Investment Analysis and Advice - Stock Traders Daily

Dec 04, 2024

Dec 04, 2024

Bamco Inc. NY Sells 25,000 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 04, 2024

Dec 04, 2024

Erste Asset Management GmbH Makes New Investment in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 04, 2024

Dec 02, 2024

Baker BROS. Advisors LP Raises Holdings in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 02, 2024

Dec 01, 2024

Fmr LLC Increases Stock Position in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 01, 2024

Dec 01, 2024

Intech Investment Management LLC Buys Shares of 21,825 Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Dec 01, 2024

Nov 29, 2024

Algert Global LLC Sells 83,969 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Contrasting Immunovant (NASDAQ:IMVT) and enGene (NASDAQ:ENGN) - Defense World

Nov 28, 2024

Nov 27, 2024

Immunovant, Inc. (NASDAQ:IMVT) Receives $48.10 Average Target Price from Analysts - Defense World

Nov 27, 2024

Nov 25, 2024

Have Immunovant Insiders Been Selling Stock? - Simply Wall St

Nov 25, 2024

Nov 24, 2024

Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Buy" by Brokerages - MarketBeat

Nov 24, 2024

Nov 24, 2024

KBC Group NV Purchases 612 Shares of Immunovant, Inc. (NASDAQ:IMVT) - Defense World

Nov 24, 2024

Nov 24, 2024

Connor Clark & Lunn Investment Management Ltd. Sells 56,789 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 24, 2024

Nov 23, 2024

Trend Tracker for (IMVT) - Stock Traders Daily

Nov 23, 2024

Nov 23, 2024

Immunovant, Inc. (NASDAQ:IMVT) CFO Sells $106,228.30 in Stock - MarketBeat

Nov 23, 2024

Nov 23, 2024

Insider Selling: Immunovant, Inc. (NASDAQ:IMVT) CEO Sells 16,692 Shares of Stock - MarketBeat

Nov 23, 2024

Nov 23, 2024

Immunovant CEO Peter Salzmann sells shares for $424,811 By Investing.com - Investing.com South Africa

Nov 23, 2024

Nov 23, 2024

Immunovant CFO Eva Renee Barnett sells $106,228 in stock By Investing.com - Investing.com South Africa

Nov 23, 2024

Nov 22, 2024

Immunovant CEO Peter Salzmann sells shares for $424,811 - Investing.com

Nov 22, 2024

Nov 22, 2024

Immunovant CFO Eva Renee Barnett sells $106,228 in stock - Investing.com

Nov 22, 2024

Nov 22, 2024

Immunovant, Inc. (NASDAQ:IMVT) Shares Bought by Victory Capital Management Inc. - Defense World

Nov 22, 2024

Nov 22, 2024

Victory Capital Management Inc. Has $9.56 Million Stake in Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 22, 2024

Nov 21, 2024

Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024? - Insider Monkey

Nov 21, 2024

Nov 20, 2024

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus - MSN

Nov 20, 2024

Nov 20, 2024

Immunovant stock hits 52-week low at $24.66 amid market shifts - Investing.com Nigeria

Nov 20, 2024

Nov 13, 2024

Principal Financial Group Inc. Purchases 391,436 Shares of Immunovant, Inc. (NASDAQ:IMVT) - MarketBeat

Nov 13, 2024

Nov 13, 2024

(IMVT) Technical Data - Stock Traders Daily

Nov 13, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition of Immunovant Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 11, 2024

Immunovant: Pipeline Progressing With One Minor Delay (NASDAQ:IMVT) - Seeking Alpha

Nov 11, 2024

Nov 09, 2024

Immunovant (NASDAQ:IMVT) Posts Earnings Results, Misses Expectations By $0.15 EPS - MarketBeat

Nov 09, 2024

Nov 09, 2024

Analysts Provide An Important Insights On Immunovant Inc (IMVT) - Stocks Register

Nov 09, 2024

Nov 08, 2024

Immunovant’s Strategic Advances in Autoimmune Therapies - TipRanks

Nov 08, 2024

Nov 08, 2024

Interesting IMVT Put And Call Options For March 2025 - Nasdaq

Nov 08, 2024

Nov 08, 2024

Immunovant's (IMVT) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 08, 2024